Title : Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.

Pub. Date : 2007 Dec 15

PMID : 18094423






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Drugs that induce cytochrome P450 3A4, such as EIAEDs, significantly affect the pharmacokinetics of temsirolimus and its active metabolite, sirolimus. Sirolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens